Bone and joint infections caused by Clostridium perfringens: a case series. 2021

Margaux Visse, and Véronique Vernet-Garnier, and Odile Bajolet, and Delphine Lebrun, and Morgane Bonnet, and Maxime Hentzien, and Xavier Ohl, and Saidou Diallo, and Firouzé Bani-Sadr
Department of Internal Medicine and Infectious Diseases, Reims Teaching Hospitals, Avenue du Général Koenig, 51092, Reims, France.

The objective of this study was to evaluate antimicrobial therapy outcomes of bone and joint infections (BJI) caused by Clostridium perfringens. We investigated remission of symptoms and the absence of relapse or reinfection during follow-up. Among the 8 patients with C. perfringens BJI, the type of infection was early prosthesis infection (n = 2), osteosynthetic device infection (n = 4), and chronic osteomyeletis (n = 2). Clindamycin-rifampicin combination was given in 4 cases and metronidazole in 4 cases. The overall success rate was 87.5%. Among the 7 patients who completed antibiotic treatment, the success rate was 100%. The clindamycin-rifampicin combination appeared to be effective in patients with C. perfringens BJI.

UI MeSH Term Description Entries
D007592 Joint Diseases Diseases involving the JOINTS. Arthropathies,Arthropathy,Joint Disease
D008297 Male Males
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001847 Bone Diseases Diseases of BONES. Bone Disease,Disease, Bone,Diseases, Bone
D002981 Clindamycin An antibacterial agent that is a semisynthetic analog of LINCOMYCIN. 7-Chloro-7-deoxylincomycin,Chlolincocin,Chlorlincocin,Cleocin,Clindamycin Hydrochloride,Clindamycin Monohydrochloride,Clindamycin Monohydrochloride, Monohydrate,Dalacin C,7 Chloro 7 deoxylincomycin,Hydrochloride, Clindamycin,Monohydrate Clindamycin Monohydrochloride,Monohydrochloride, Clindamycin,Monohydrochloride, Monohydrate Clindamycin
D003015 Clostridium Infections Infections with bacteria of the genus CLOSTRIDIUM and closely related CLOSTRIDIOIDES species. Clostridioides Infections,Clostridioides difficile Infection,Clostridioides perfringens Food Poisoning,Clostridioides perfringens Infections,Clostridioides sordellii Infection,Clostridium difficile Infections,Clostridium sordellii Infections,Clostridium difficile Infection,Clostridium perfringens Food Poisoning,Clostridium perfringens Infections,Clostridium sordellii Infection,Infections, Clostridium,Clostridioides Infection,Clostridioides perfringens Infection,Clostridium Infection,Clostridium perfringens Infection,Infection, Clostridioides difficile,Infection, Clostridioides sordellii,Infection, Clostridium,Infection, Clostridium difficile,Infection, Clostridium sordellii
D003016 Clostridium perfringens The most common etiologic agent of GAS GANGRENE. It is differentiable into several distinct types based on the distribution of twelve different toxins. Clostridium welchii
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Margaux Visse, and Véronique Vernet-Garnier, and Odile Bajolet, and Delphine Lebrun, and Morgane Bonnet, and Maxime Hentzien, and Xavier Ohl, and Saidou Diallo, and Firouzé Bani-Sadr
January 1964, Microbiologia, parazitologia, epidemiologia,
Margaux Visse, and Véronique Vernet-Garnier, and Odile Bajolet, and Delphine Lebrun, and Morgane Bonnet, and Maxime Hentzien, and Xavier Ohl, and Saidou Diallo, and Firouzé Bani-Sadr
February 2023, The Lancet. Infectious diseases,
Margaux Visse, and Véronique Vernet-Garnier, and Odile Bajolet, and Delphine Lebrun, and Morgane Bonnet, and Maxime Hentzien, and Xavier Ohl, and Saidou Diallo, and Firouzé Bani-Sadr
November 1969, The American review of respiratory disease,
Margaux Visse, and Véronique Vernet-Garnier, and Odile Bajolet, and Delphine Lebrun, and Morgane Bonnet, and Maxime Hentzien, and Xavier Ohl, and Saidou Diallo, and Firouzé Bani-Sadr
August 1965, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
Margaux Visse, and Véronique Vernet-Garnier, and Odile Bajolet, and Delphine Lebrun, and Morgane Bonnet, and Maxime Hentzien, and Xavier Ohl, and Saidou Diallo, and Firouzé Bani-Sadr
June 1983, Canadian Medical Association journal,
Margaux Visse, and Véronique Vernet-Garnier, and Odile Bajolet, and Delphine Lebrun, and Morgane Bonnet, and Maxime Hentzien, and Xavier Ohl, and Saidou Diallo, and Firouzé Bani-Sadr
January 1957, Khirurgiia,
Margaux Visse, and Véronique Vernet-Garnier, and Odile Bajolet, and Delphine Lebrun, and Morgane Bonnet, and Maxime Hentzien, and Xavier Ohl, and Saidou Diallo, and Firouzé Bani-Sadr
August 1959, Revue medicale de Liege,
Margaux Visse, and Véronique Vernet-Garnier, and Odile Bajolet, and Delphine Lebrun, and Morgane Bonnet, and Maxime Hentzien, and Xavier Ohl, and Saidou Diallo, and Firouzé Bani-Sadr
January 1997, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
Margaux Visse, and Véronique Vernet-Garnier, and Odile Bajolet, and Delphine Lebrun, and Morgane Bonnet, and Maxime Hentzien, and Xavier Ohl, and Saidou Diallo, and Firouzé Bani-Sadr
February 2023, Future microbiology,
Margaux Visse, and Véronique Vernet-Garnier, and Odile Bajolet, and Delphine Lebrun, and Morgane Bonnet, and Maxime Hentzien, and Xavier Ohl, and Saidou Diallo, and Firouzé Bani-Sadr
January 1998, Rontgenpraxis; Zeitschrift fur radiologische Technik,
Copied contents to your clipboard!